Literature DB >> 33588795

Patient perspective of tardive dyskinesia: results from a social media listening study.

Mallory Farrar1, Leslie Lundt2, Ericha Franey2, Chuck Yonan2.   

Abstract

BACKGROUND: Tardive dyskinesia (TD) is a persistent and potentially disabling movement disorder associated with prolonged exposure to dopamine receptor blocking agents such as antipsychotics. With the expanding use of antipsychotics, research is needed to better understand patient perspectives of TD, which clinical assessments may fail to capture. Social media listening (SML), which is recognized by the US FDA as a method that can advance ongoing efforts for more patient-focused drug development, has been used to understand patient experiences in other disease states. This is the first study to use SML analysis of unsolicited patient and caregiver insights to help clinicians understand how patients describe their symptoms, the emotional distress associated with TD, and the impact on caregivers.
METHODS: In this pilot study, a comprehensive search was performed for publicly available, English-language, online content posted between March 2017 and November 2019 on social media platforms, blogs, and forums. An analytics platform (NetBase™) identified posts containing patient or caregiver experiences of assumed TD using predefined search terms. All posts were manually curated and reviewed to ensure quality and validity of the post and to further classify key symptoms, sentiments, and themes.
RESULTS: A total of 261 posts from patients/caregivers ("patient insights") were identified using predefined search terms; 107 posts were used for these analyses. Posts were primarily from forums (47%) and Twitter (33%). Analysis of the most common sentiment-related terms (e.g. "feel" [n = 31], "worse" [n = 17], "symptom" [n = 14], "better" [n = 12]) indicated that 64% were negative, 33% were neutral, and 3% were positive. Theme analysis revealed that patients often felt angry about having TD from a medication used to treat a different condition. In addition, patients felt insecure, including feeling unaccepted by society and fear of being judged by others.
CONCLUSION: Although this study was limited by inherent methodological constraints (e.g., small sample size, reliance on patient self-report), the perspectives generated from analyzing social media may help convey the unmet needs of patients with TD. This analysis indicated that movement-related symptoms are the most common patient concern, resulting in strong feelings of anger and insecurity.

Entities:  

Keywords:  Antipsychotics; Disease burden; Patient perspective; Social media listening; Tardive dyskinesia

Year:  2021        PMID: 33588795      PMCID: PMC7885234          DOI: 10.1186/s12888-021-03074-9

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN: 1471-244X            Impact factor:   3.630


  19 in total

1.  Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial.

Authors:  Karen E Anderson; David Stamler; Mat D Davis; Stewart A Factor; Robert A Hauser; Jouko Isojärvi; L Fredrik Jarskog; Joohi Jimenez-Shahed; Rajeev Kumar; Joseph P McEvoy; Stanislaw Ochudlo; William G Ondo; Hubert H Fernandez
Journal:  Lancet Psychiatry       Date:  2017-06-28       Impact factor: 27.083

2.  The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study.

Authors:  Stewart A Factor; Gary Remington; Cynthia L Comella; Christoph U Correll; Joshua Burke; Roland Jimenez; Grace S Liang; Christopher F O'Brien
Journal:  J Clin Psychiatry       Date:  2017 Nov/Dec       Impact factor: 4.384

3.  Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis.

Authors:  Rakesh Jain; Christoph U Correll
Journal:  J Clin Psychiatry       Date:  2018-03-20       Impact factor: 4.384

Review 4.  Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment.

Authors:  Christoph U Correll; John M Kane; Leslie L Citrome
Journal:  J Clin Psychiatry       Date:  2017 Sep/Oct       Impact factor: 4.384

5.  Patients' perspectives on COPD: findings from a social media listening study.

Authors:  Nigel S Cook; Konstantinos Kostikas; Jean-Bernard Gruenberger; Bhavik Shah; Purnima Pathak; Vinay Preet Kaur; Alaknanda Mudumby; Rajat Sharma; Florian S Gutzwiller
Journal:  ERJ Open Res       Date:  2019-02-11

6.  Evaluating Patient Experiences in Dry Eye Disease Through Social Media Listening Research.

Authors:  Nigel Cook; Anmol Mullins; Raju Gautam; Sharath Medi; Clementine Prince; Nishith Tyagi; Jyothi Kommineni
Journal:  Ophthalmol Ther       Date:  2019-06-03

Review 7.  Role of Vesicular Monoamine Transporter 2 Inhibitors in Tardive Dyskinesia Management.

Authors:  Venkatesh Sreeram; Shanila Shagufta; Faisal Kagadkar
Journal:  Cureus       Date:  2019-08-24

8.  Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia.

Authors:  Hubert H Fernandez; David Stamler; Mat D Davis; Stewart A Factor; Robert A Hauser; Joohi Jimenez-Shahed; William G Ondo; L Fredrik Jarskog; Scott W Woods; Danny Bega; Mark S LeDoux; David R Shprecher; Karen E Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-07-10       Impact factor: 10.154

9.  NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study.

Authors:  Christopher F O'Brien; Roland Jimenez; Robert A Hauser; Stewart A Factor; Joshua Burke; Daniel Mandri; Julio C Castro-Gayol
Journal:  Mov Disord       Date:  2015-09-08       Impact factor: 10.338

10.  RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings.

Authors:  Stanley N Caroff; Karen Yeomans; William R Lenderking; Andrew J Cutler; Caroline M Tanner; Huda Shalhoub; Véronique Pagé; Jun Chen; Ericha Franey; Chuck Yonan
Journal:  J Clin Psychopharmacol       Date:  2020 May/Jun       Impact factor: 3.118

View more
  1 in total

1.  Areas of Interest and Social Consideration of Antidepressants on English Tweets: A Natural Language Processing Classification Study.

Authors:  Laura de Anta; Miguel Angel Alvarez-Mon; Miguel A Ortega; Cristina Salazar; Carolina Donat-Vargas; Javier Santoma-Vilaclara; Maria Martin-Martinez; Guillermo Lahera; Luis Gutierrez-Rojas; Roberto Rodriguez-Jimenez; Javier Quintero; Melchor Alvarez-Mon
Journal:  J Pers Med       Date:  2022-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.